undefined
EUTM file information

019149141

TARGED TARGETED ENZYME DELIVERY


February 26, 2025

Trademark Summary

The trademark application TARGED TARGETED ENZYME DELIVERY was filed by TargED Biopharmaceuticals B.V., a corporation established under the laws of the Kingdom of the Netherlands (the "Applicant"). Application under examination.

The application was filed in English (French was selected as the second language).


Goods And Services

  • The mark was filed in class 5 with following description of goods:
    1. Pharmaceutical preparations
    2. Medical preparations
    3. Dietary supplements for medical purposes
    4. Medicinal herbs and extracts
    5. Drugs for medical purposes, pharmaceutical preparations for the prevention and treatment of thrombosis
    6. Antithrombotic agents
    7. Thrombolytic drugs
    8. Coagulation inhibitors
    9. Anticoagulants
    10. Platelet aggregation inhibitors
    11. Hemostatic agents
    12. Blood thinners for medical use
    13. Therapeutic compounds for thrombosis
    14. Pharmaceutical preparations for cardiovascular diseases
    15. Pharmaceutical preparations for blood clotting disorders
    16. Injectable or intravenous solutions for thrombosis treatment
    17. Medicinal products for the treatment of deep vein thrombosis (DVT)
    18. Medicinal products for pulmonary embolism (PE) management
    19. Preclinical or clinical trial medicines for thrombosis research
    20. Pharmaceuticals for vascular diseases.
  • The mark was filed in class 42 with following description of goods:
    1. Scientific and technological services
    2. Research and development services
    3. Laboratory and clinical testing
    4. Biotechnology research services
    5. Pharmaceutical research services
    6. Medical and scientific laboratory services
    7. Medical research and development services
    8. Research and development in the field of thrombosis treatment
    9. Pharmaceutical and biotechnology research for antithrombotic drugs
    10. Preclinical and clinical testing of drugs for thrombosis
    11. Drug discovery services related to thrombosis
    12. Development of biopharmaceuticals for cardiovascular diseases
    13. Research in the field of platelet aggregation inhibitors
    14. Consultancy services in pharmaceutical research and development
    15. Scientific studies related to thrombosis and blood clotting disorders
    16. Clinical trials for thrombosis drugs and therapies
    17. Design and implementation of drug efficacy studies for thrombosis treatment
    18. Genetic research and molecular biology services related to thrombosis
    19. Data analysis and modeling for thrombosis treatments
    20. Laboratory services for thrombosis diagnosis and testing
    21. Research services related to anticoagulation therapy
    22. Research in personalized medicine for thrombosis patients
    23. Services related to regulatory compliance for drug development in thrombosis
    24. Research and development services for biotechnological solutions for thrombosis
    25. Scientific advisory and consultation services in thrombosis research.